Atreca raises $56M in series A

Atreca Inc. (Redwood City, Calif.) closed a $56 million series A round led by an undisclosed U.S. healthcare-focused fund. The Bill & Melinda Gates Foundation, Mission Bay Capital and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) also participated.

Atreca is developing preclinical cancer immunotherapies using its Immune Repertoire Capture technology. The company gained rights from Stanford University to the technology, which uses next-generation sequencing to identify antibodies produced during an immune response. ...